Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study. - Concepedia

Concepedia

Publication | Closed Access

Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.

57

Citations

31

References

1998

Year

Klaus Laczika, Matthew D. Novak, Bernadette Hilgarth, Margit Mitterbauer, Gerlinde Mitterbauer, A Scheidel-Petrovic, C.M. Scholten, Renate Thalhammer-Scherrer, S. Brugger, Fee Keil,

Journal of Clinical Oncology

Abstract

Competitive RT-PCR is a valuable tool for molecular monitoring during postremission chemotherapy, as well as after BMT.

References

	Year	Citations

Page 1